United States · FDA National Drug Code directory
Quetiapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-519_41a41d6e-d9e9-4f2d-e063-6394a90aa6f5
- Product NDC
- 76420-519
- Form
- TABLET, FILM COATED
- Composition / generic term
- Quetiapine
- Labeler
- ASCLEMED USA INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130301
- Source listing expiry
- 20261231
Source-listed ingredients
- QUETIAPINE FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (76420-519-01) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 76420-519-01
- 10 TABLET, FILM COATED in 1 BOTTLE (76420-519-10) · 76420-519-10
- 20 TABLET, FILM COATED in 1 BOTTLE (76420-519-20) · 76420-519-20
- 30 TABLET, FILM COATED in 1 BOTTLE (76420-519-30) · 76420-519-30
- 60 TABLET, FILM COATED in 1 BOTTLE (76420-519-60) · 76420-519-60
- 90 TABLET, FILM COATED in 1 BOTTLE (76420-519-90) · 76420-519-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →